These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28065862)

  • 1. Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction.
    Allijn IE; Czarny BMS; Wang X; Chong SY; Weiler M; da Silva AE; Metselaar JM; Lam CSP; Pastorin G; de Kleijn DPV; Storm G; Wang JW; Schiffelers RM
    J Control Release; 2017 Feb; 247():127-133. PubMed ID: 28065862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting and modulating infarct macrophages with hemin formulated in designed lipid-based particles improves cardiac remodeling and function.
    Ben-Mordechai T; Kain D; Holbova R; Landa N; Levin LP; Elron-Gross I; Glucksam-Galnoy Y; Feinberg MS; Margalit R; Leor J
    J Control Release; 2017 Jul; 257():21-31. PubMed ID: 28065861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy.
    Zhang YJ; Yang SH; Li MH; Iqbal J; Bourantas CV; Mi QY; Yu YH; Li JJ; Zhao SL; Tian NL; Chen SL
    Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):995-1002. PubMed ID: 25224725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
    Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicorandil alleviates myocardial injury and post-infarction cardiac remodeling by inhibiting Mst1.
    Wang S; Fan Y; Feng X; Sun C; Shi Z; Li T; Lv J; Yang Z; Zhao Z; Sun D
    Biochem Biophys Res Commun; 2018 Jan; 495(1):292-299. PubMed ID: 29127009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GYY4137 attenuates remodeling, preserves cardiac function and modulates the natriuretic peptide response to ischemia.
    Lilyanna S; Peh MT; Liew OW; Wang P; Moore PK; Richards AM; Martinez EC
    J Mol Cell Cardiol; 2015 Oct; 87():27-37. PubMed ID: 26254181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction.
    Hamid T; Ismahil MA; Bansal SS; Patel B; Goel M; White CR; Anantharamaiah GM; Prabhu SD
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of resveratrol (trans-3,5,4'-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction.
    Burstein B; Maguy A; Clément R; Gosselin H; Poulin F; Ethier N; Tardif JC; Hébert TE; Calderone A; Nattel S
    J Pharmacol Exp Ther; 2007 Dec; 323(3):916-23. PubMed ID: 17875610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced adipocyte cell-sheet ameliorates cardiac dysfunction in a mouse myocardial infarction model: a novel drug delivery system for heart failure.
    Imanishi Y; Miyagawa S; Maeda N; Fukushima S; Kitagawa-Sakakida S; Daimon T; Hirata A; Shimizu T; Okano T; Shimomura I; Sawa Y
    Circulation; 2011 Sep; 124(11 Suppl):S10-7. PubMed ID: 21911798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease.
    Al-Darraji A; Haydar D; Chelvarajan L; Tripathi H; Levitan B; Gao E; Venditto VJ; Gensel JC; Feola DJ; Abdel-Latif A
    PLoS One; 2018; 13(7):e0200474. PubMed ID: 30001416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress.
    Zhao GL; Yu LM; Gao WL; Duan WX; Jiang B; Liu XD; Zhang B; Liu ZH; Zhai ME; Jin ZX; Yu SQ; Wang Y
    Acta Pharmacol Sin; 2016 Mar; 37(3):354-67. PubMed ID: 26806299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of anti-inflammatory and anti-angiogenic activity of berberine by novel rapid dissolving nanoemulsifying technique.
    Pund S; Borade G; Rasve G
    Phytomedicine; 2014 Feb; 21(3):307-14. PubMed ID: 24176841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosemary supplementation (Rosmarinus oficinallis L.) attenuates cardiac remodeling after myocardial infarction in rats.
    Murino Rafacho BP; Portugal Dos Santos P; Gonçalves AF; Fernandes AAH; Okoshi K; Chiuso-Minicucci F; Azevedo PS; Mamede Zornoff LA; Minicucci MF; Wang XD; Rupp de Paiva SA
    PLoS One; 2017; 12(5):e0177521. PubMed ID: 28494028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.
    Kain V; Ingle KA; Colas RA; Dalli J; Prabhu SD; Serhan CN; Joshi M; Halade GV
    J Mol Cell Cardiol; 2015 Jul; 84():24-35. PubMed ID: 25870158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratiometric Delivery of Mitoxantrone and Berberine Co-encapsulated Liposomes to Improve Antitumor Efficiency and Decrease Cardiac Toxicity.
    Yang Z; Zhao L; Wang X; He Z; Wang Y
    AAPS PharmSciTech; 2021 Jan; 22(1):46. PubMed ID: 33442785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction.
    Al-Darraji A; Donahue RR; Tripathi H; Peng H; Levitan BM; Chelvarajan L; Haydar D; Gao E; Henson D; Gensel JC; Feola DJ; Venditto VJ; Abdel-Latif A
    Sci Rep; 2020 Oct; 10(1):16596. PubMed ID: 33024189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin prevents adverse myocardial infarction remodeling via Notch1/Mfn2 pathway.
    Pei H; Du J; Song X; He L; Zhang Y; Li X; Qiu C; Zhang Y; Hou J; Feng J; Gao E; Li D; Yang Y
    Free Radic Biol Med; 2016 Aug; 97():408-417. PubMed ID: 27387769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of interleukin-37 on cardiac function after myocardial infarction in mice.
    Xu D; Wang A; Jiang F; Hu J; Zhang X
    Int J Clin Exp Pathol; 2015; 8(5):5247-51. PubMed ID: 26191225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effectiveness of a single vs multiple doses of erythropoietin after experimental myocardial infarction in rats.
    Moon C; Krawczyk M; Lakatta EG; Talan MI
    Cardiovasc Drugs Ther; 2006 Aug; 20(4):245-51. PubMed ID: 17019537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.